{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T10:49:59Z","timestamp":1649155799679},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.prp.2017.11.021","type":"journal-article","created":{"date-parts":[[2017,12,2]],"date-time":"2017-12-02T07:19:57Z","timestamp":1512199197000},"page":"207-212","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinicopathologic features of adult EBV-associated B-cell lymphoproliferative disease"],"prefix":"10.1016","volume":"214","author":[{"given":"Sonja","family":"W\u00f6rner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Konrad","family":"Mueller-Hermelink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Ullrich","family":"Voelker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.prp.2017.11.021_bib0005","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/ajcp\/aqw214","article-title":"EBV-positive B-cell proliferations of varied malignant potential: 2015 SH\/EAHP workshop report-part 1","volume":"147","author":"Natkunam","year":"2017","journal-title":"Am. J. Clin. Pathol."},{"issue":"4","key":"10.1016\/j.prp.2017.11.021_bib0010","doi-asserted-by":"crossref","first-page":"352","DOI":"10.4132\/jptm.2017.03.15","article-title":"Hematopathology study group of the Korean society of pathologists, Epstein-Barr virus-associated lymphoproliferative disorders: review and update on 2016 WHO classification","volume":"51","author":"Kim","year":"2017","journal-title":"J. Pathol. Transl. Med."},{"issue":"January (47)","key":"10.1016\/j.prp.2017.11.021_bib0015","first-page":"e132","article-title":"EBV-driven B-cell lymphoproliferative disorders: from biology, classification and differential diagnosis to clinical management","volume":"23","author":"Ok","year":"2014","journal-title":"Exp. Mol. Med"},{"issue":"4","key":"10.1016\/j.prp.2017.11.021_bib0020","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1309\/B3WH-QWBY-YV61-CE46","article-title":"The molecular characterization of fatal infectious mononucleosis","volume":"117","author":"Wick","year":"2002","journal-title":"Am. J. Clin. Pathol."},{"issue":"4","key":"10.1016\/j.prp.2017.11.021_bib0025","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1086\/367988","article-title":"Prognostic factors of chronic active Epstein-Barr virus infection","volume":"187","author":"Kimura","year":"2003","journal-title":"J. Infect. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.prp.2017.11.021_bib0030","first-page":"285","article-title":"EBV reactivation syndromes in adults without known immunodeficiency","volume":"22","author":"Schrager","year":"2009","journal-title":"Mod. Pathol."},{"issue":"9","key":"10.1016\/j.prp.2017.11.021_bib0035","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/annonc\/mdp064","article-title":"Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting","volume":"20","author":"Cohen","year":"2009","journal-title":"Ann. Oncol."},{"issue":"8","key":"10.1016\/j.prp.2017.11.021_bib0040","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.prp.2007.05.002","article-title":"Epstein-Barr virus-related reactive lymphoproliferative disorders in middle-aged or elderly patients presenting with atypical features. A clinicopathological study of six cases","volume":"203","author":"Kojima","year":"2007","journal-title":"Pathol. Res. Pract."},{"issue":"6","key":"10.1016\/j.prp.2017.11.021_bib0045","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2350\/07-12-0386.1","article-title":"Fatal non-transplant-related Epstein-Barr virus-associated atypical lymphoid proliferations in infants and children: a clinicopathologic study","volume":"11","author":"Salama","year":"2008","journal-title":"Pediatr. Dev. Pathol."},{"issue":"2","key":"10.1016\/j.prp.2017.11.021_bib0050","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1084-8592(99)80036-8","article-title":"Enhanced sensitivity with a novel TCRgamma PCR assay for clonality studies in 569 formalin-fixed, paraffin-embedded (FFPE) cases","volume":"4","author":"Krafft","year":"1999","journal-title":"Mol. Diagn."},{"issue":"1","key":"10.1016\/j.prp.2017.11.021_bib0055","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1525-1578(10)60678-2","article-title":"Lymphoid tissues from patients with infectious mononucleosis lack monoclonal B and T cells","volume":"4","author":"Plumbley","year":"2002","journal-title":"J. Mol. Diagn."},{"issue":"2","key":"10.1016\/j.prp.2017.11.021_bib0060","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/modpathol.2010.186","article-title":"Presence of monoclonal T-cell populations in B-cell post-transplant lymphoproliferative disorders","volume":"24","author":"Ibrahim","year":"2011","journal-title":"Mod. Pathol."},{"issue":"1","key":"10.1016\/j.prp.2017.11.021_bib0065","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/ejh.12116","article-title":"Methotrexate\/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression","volume":"91","author":"Ichikawa","year":"2013","journal-title":"Eur. J. Haematol."},{"issue":"5","key":"10.1016\/j.prp.2017.11.021_bib0070","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1309\/AJCP2G0VKTKPNPRR","article-title":"A look into the evolution of Epstein-Barr virus-induced lymphoproliferative disorders: a case study","volume":"144","author":"Ambrosio","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"issue":"2","key":"10.1016\/j.prp.2017.11.021_bib0075","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1182\/blood.V96.2.443","article-title":"Fulminant EBV(+) T-cell lymphoproliferative disorder following acute\/chronic EBV infection: a distinct clinicopathologic syndrome","volume":"96","author":"Quintanilla-Martinez","year":"2000","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.prp.2017.11.021_bib0080","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0002-9440(10)65119-X","article-title":"Interleukin-18, interferon-gamma, IP-10, and Mig expression in Epstein-Barr virus-induced infectious mononucleosis and posttransplant lymphoproliferative disease","volume":"155","author":"Setsuda","year":"1999","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.prp.2017.11.021_bib0085","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF02990933","article-title":"Atypical clonal T-cell proliferation in infectious mononucleosis","volume":"13","author":"Malik","year":"1996","journal-title":"Med. Oncol."},{"issue":"3","key":"10.1016\/j.prp.2017.11.021_bib0090","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/ajcp\/98.3.324","article-title":"Primary Epstein-Barr virus infection with clonal T-cell lymphoproliferation","volume":"98","author":"Gaillard","year":"1992","journal-title":"Am. J. Clin. Pathol."},{"issue":"3","key":"10.1016\/j.prp.2017.11.021_bib0095","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3109\/00365548709018485","article-title":"Fulminant course of infectious mononucleosis with virus-associated hemophagocytic syndrome","volume":"19","author":"Christensson","year":"1987","journal-title":"Scand. J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.prp.2017.11.021_bib0100","first-page":"481","article-title":"Epstein-Barr virus-associated lymphoproliferative disorder. Applications of immunoperoxidase and molecular biologic techniques","volume":"113","author":"Kornstein","year":"1989","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"22","key":"10.1016\/j.prp.2017.11.021_bib0105","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.1182\/blood-2010-11-316745","article-title":"Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States","volume":"117","author":"Cohen","year":"2011","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.prp.2017.11.021_bib0110","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s12185-017-2192-6","article-title":"How we treat chronic active Epstein-Barr virus infection","volume":"105","author":"Sawada","year":"2017","journal-title":"Int. J. Hematol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033817307628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033817307628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T15:49:36Z","timestamp":1603468176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033817307628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0344033817307628"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2017.11.021","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinicopathologic features of adult EBV-associated B-cell lymphoproliferative disease","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2017.11.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}